Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial

Increased urinary albumin excretion in diabetes not only signals nephropathy but also serves as a risk marker for cardiovascular disease. The data of MARCH (Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment) trial demonstrated that acarbose and metformin were similarly efficac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Pan, Qingrong, Xu, Yuan, Yang, Ning, Gao, Xia, Liu, Jia, Yang, Wenying, Wang, Guang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2016
Konular:
4300
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998782/
https://ncbi.nlm.nih.gov/pubmed/27057866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003247
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller